- Home
- NBY vs VIRT Comparison
NBY vs VIRT Comparison
Compare NBY & VIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBY
- VIRT
- Stock Information
- Founded
- NBY 2000
- VIRT 2008
- Country
- NBY United States
- VIRT United States
- Employees
- NBY N/A
- VIRT N/A
- Industry
- NBY
- VIRT Investment Bankers/Brokers/Service
- Sector
- NBY
- VIRT Finance
- Exchange
- NBY Nasdaq
- VIRT Nasdaq
- Market Cap
- NBY 15.7M
- VIRT 3.5B
- IPO Year
- NBY 2007
- VIRT 2015
- Fundamental
- Price
- NBY $1.75
- VIRT $35.17
- Analyst Decision
- NBY Strong Buy
- VIRT Hold
- Analyst Count
- NBY 1
- VIRT 8
- Target Price
- NBY $0.85
- VIRT $39.75
- AVG Volume (30 Days)
- NBY 21.1M
- VIRT 1.1M
- Earning Date
- NBY 11-06-2025
- VIRT 10-23-2025
- Dividend Yield
- NBY N/A
- VIRT 2.73%
- EPS Growth
- NBY N/A
- VIRT 122.21
- EPS
- NBY 0.41
- VIRT 4.40
- Revenue
- NBY $9,781,000.00
- VIRT $2,617,631,000.00
- Revenue This Year
- NBY $23.91
- VIRT N/A
- Revenue Next Year
- NBY $32.05
- VIRT N/A
- P/E Ratio
- NBY $4.97
- VIRT $8.00
- Revenue Growth
- NBY 113.47
- VIRT 42.88
- 52 Week Low
- NBY $0.46
- VIRT $29.82
- 52 Week High
- NBY $4.44
- VIRT $45.77
- Technical
- Relative Strength Index (RSI)
- NBY 48.05
- VIRT 18.92
- Support Level
- NBY $2.28
- VIRT $40.81
- Resistance Level
- NBY $3.30
- VIRT $38.85
- Average True Range (ATR)
- NBY 0.64
- VIRT 1.13
- MACD
- NBY -0.10
- VIRT -0.51
- Stochastic Oscillator
- NBY 10.03
- VIRT 4.43
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
About VIRT Virtu Financial Inc.
Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.